Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
10-year follow-up of condoliase chemonucleolysis after Phase III trial
jRCT1040220134Completed
- Sponsor
- Seikagaku Corporation
- Start
- Mar 2023
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of condoliase in Herniated Lumbar Disk, sponsored by Seikagaku Corporation. Primary endpoints: Disc height, Posterior intervertebral angle and 3 more. Started Mar 2023; status: completed.
02
Drugs
condoliase
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on jRCT1040220134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1040220134.